CN100484550C - 用于治疗肿瘤放、化疗后白细胞减少症的中成药及其制备方法 - Google Patents
用于治疗肿瘤放、化疗后白细胞减少症的中成药及其制备方法 Download PDFInfo
- Publication number
- CN100484550C CN100484550C CNB2004100444136A CN200410044413A CN100484550C CN 100484550 C CN100484550 C CN 100484550C CN B2004100444136 A CNB2004100444136 A CN B2004100444136A CN 200410044413 A CN200410044413 A CN 200410044413A CN 100484550 C CN100484550 C CN 100484550C
- Authority
- CN
- China
- Prior art keywords
- hours
- chemotherapy
- relative density
- preparation
- under reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 238000002512 chemotherapy Methods 0.000 title claims abstract description 21
- 201000002364 leukopenia Diseases 0.000 title claims abstract description 19
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 18
- 231100001022 leukopenia Toxicity 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims description 27
- 238000001959 radiotherapy Methods 0.000 title abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 72
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000009636 Huang Qi Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 230000008569 process Effects 0.000 claims abstract description 4
- 238000009472 formulation Methods 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims description 33
- 241000208340 Araliaceae Species 0.000 claims description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 20
- 235000008434 ginseng Nutrition 0.000 claims description 20
- 241000222640 Polyporus Species 0.000 claims description 18
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 239000008187 granular material Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 238000004064 recycling Methods 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 11
- 239000008107 starch Substances 0.000 claims description 11
- 235000019698 starch Nutrition 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 206010013786 Dry skin Diseases 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 238000010025 steaming Methods 0.000 abstract description 12
- 230000036737 immune function Effects 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 7
- 230000007812 deficiency Effects 0.000 abstract description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 5
- 206010013781 dry mouth Diseases 0.000 abstract description 5
- 206010022437 insomnia Diseases 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 206010028372 Muscular weakness Diseases 0.000 abstract description 3
- 230000036473 myasthenia Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract description 2
- 241000282461 Canis lupus Species 0.000 abstract 1
- 241000735234 Ligustrum Species 0.000 abstract 1
- 240000002624 Mespilus germanica Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 244000171085 Polyporus umbellatus Species 0.000 abstract 1
- 235000004837 Polyporus umbellatus Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 230000036528 appetite Effects 0.000 abstract 1
- 235000019789 appetite Nutrition 0.000 abstract 1
- 238000010411 cooking Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000005946 Xerostomia Diseases 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- -1 filter Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 208000030208 low-grade fever Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010024264 Lethargy Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100444136A CN100484550C (zh) | 2003-09-25 | 2004-04-27 | 用于治疗肿瘤放、化疗后白细胞减少症的中成药及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN03134611.1 | 2003-09-25 | ||
CN03134611 | 2003-09-25 | ||
CNB2004100444136A CN100484550C (zh) | 2003-09-25 | 2004-04-27 | 用于治疗肿瘤放、化疗后白细胞减少症的中成药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1544078A CN1544078A (zh) | 2004-11-10 |
CN100484550C true CN100484550C (zh) | 2009-05-06 |
Family
ID=34378726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100444136A Expired - Lifetime CN100484550C (zh) | 2003-09-25 | 2004-04-27 | 用于治疗肿瘤放、化疗后白细胞减少症的中成药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100484550C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071057A (zh) * | 2013-01-10 | 2013-05-01 | 济南康众医药科技开发有限公司 | 一种治疗阴虚发热型癌性发热的药物 |
CN103705637B (zh) * | 2013-12-25 | 2016-05-18 | 陕西步长制药有限公司 | 一种中药组合物及其制备方法 |
CN104740077B (zh) * | 2013-12-25 | 2018-03-23 | 陕西步长制药有限公司 | 一种治疗肿瘤病的中药制剂及其制备方法 |
CN112244298A (zh) * | 2020-11-26 | 2021-01-22 | 上海市肺科医院 | 一种辅助肺部肿瘤化疗的红参铁叶酸组合物及其制法 |
-
2004
- 2004-04-27 CN CNB2004100444136A patent/CN100484550C/zh not_active Expired - Lifetime
Non-Patent Citations (2)
Title |
---|
新编国家中成药. 陈勇主编,1001,人民卫生出版社. 2002 |
新编国家中成药. 陈勇主编,1001,人民卫生出版社. 2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1544078A (zh) | 2004-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101612357B (zh) | 一种治疗肿瘤的中药组合物及其制备方法 | |
CN105920514A (zh) | 治疗代谢综合征的中药组合物 | |
CN103623341A (zh) | 治疗高血压病以及由此引起心脑血管疾病的药物 | |
CN102416101B (zh) | 治疗心力衰竭的中药组合物及其制备方法 | |
CN104815166B (zh) | 一种治疗糖尿病的中药组合物及其制备和应用 | |
CN104095945A (zh) | 一种治疗慢性心力衰竭的中药组合物及其口服制剂 | |
CN101461932B (zh) | 一种治疗小儿脾虚湿热腹泻的药物组合物及其制备方法 | |
CN108619355A (zh) | 一种抗肿瘤中药组合物及其制备方法 | |
CN100484550C (zh) | 用于治疗肿瘤放、化疗后白细胞减少症的中成药及其制备方法 | |
CN104013674B (zh) | 一种治疗慢性心衰的中药组合物及其制备方法和应用 | |
CN101564464B (zh) | 一种调节肿瘤患者机体免疫力的中药药物 | |
CN102488838A (zh) | 治疗病毒性心肌炎的中药组合物 | |
CN102641357B (zh) | 一种治疗高血压的药物及其制备方法 | |
CN101940765B (zh) | 治疗慢性脑供血不足的药物及制备方法 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN102631492B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN101757423B (zh) | 一种治疗心肌炎的中药组合物及其制备方法 | |
CN1291743C (zh) | 一种治疗胃癌的中药及其制备工艺 | |
CN1836683B (zh) | 一种治疗肿瘤的药物及其制备方法 | |
CN102631486B (zh) | 一种保健组合物 | |
CN114949135B (zh) | 一种治疗化疗后消化道反应的中药组合物及其制备方法 | |
CN105687524A (zh) | 一种补气调血中药制剂 | |
CN103705637B (zh) | 一种中药组合物及其制备方法 | |
CN102631506A (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN103751692A (zh) | 一种海狗鞭特补胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANXI BUCHANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: BUCHANG MEDICAL SCIENCE + TECHNOLOGY DEVELOPING CO., LTD., XIANYANG CITY Effective date: 20100108 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100108 Address after: Box 123, Shaanxi city of Xianyang province Weiyang Road West Patentee after: Shaanxi Buchang Pharmaceuticals Co.,Ltd. Address before: Shaanxi city of Xi'an province high tech high road No. 50 Nanyang International Building, 20 floor Patentee before: Xianyang Buchang Pharmaceutical Technology Development Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20090506 |
|
CX01 | Expiry of patent term |